BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20581892)

  • 21. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Nowak B; Ostwald E; Schäfer W; Block S; Setani K; Büll U
    Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graves' disease and thyroid cancer.
    Behar R; Arganini M; Wu TC; McCormick M; Straus FH; DeGroot LJ; Kaplan EL
    Surgery; 1986 Dec; 100(6):1121-7. PubMed ID: 3787468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM; Shawkat W
    Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating and managing patients with thyrotoxicosis.
    Campbell K; Doogue M
    Aust Fam Physician; 2012 Aug; 41(8):564-72. PubMed ID: 23145395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The surgical treatment of Graves' disease].
    de Ruijter SH; van Dalen T; Muller AF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
    Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
    Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperthyroidism in the land of Graves: results of treatment by surgery, radio-iodine and carbimazole in 837 cases.
    Sugrue D; McEvoy M; Feely J; Drury MI
    Q J Med; 1980; 49(193):51-61. PubMed ID: 7433627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of surgical treatment in Graves' disease orbitopathy. Is there a correlation between the extent of thyroidectomy and the course of orbithopathy?
    Maurer E; Dănilă R; Dominguez E; Osei-Agymang T; Zielke A; Hassan I
    Chirurgia (Bucur); 2008; 103(3):291-5. PubMed ID: 18717277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile thyrotoxicosis; can we do better?
    Birrell G; Cheetham T
    Arch Dis Child; 2004 Aug; 89(8):745-50. PubMed ID: 15269076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Thyrotoxicosis in Children and Adolescents: A Turkish Multi-center Experience.
    Esen İ; Bayramoğlu E; Yıldız M; Aydın M; Karakılıç Özturhan E; Aycan Z; Bolu S; Önal H; Kör Y; Ökdemir D; Ünal E; Önder A; Evliyaoğlu O; Çayır A; Taştan M; Yüksel A; Kılınç A; Büyükinan M; Özcabı B; Akın O; Binay Ç; Kılınç S; Yıldırım R; Aytaç EH; Sağsak E
    J Clin Res Pediatr Endocrinol; 2019 May; 11(2):164-172. PubMed ID: 30488822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should radioiodine be the first-line treatment for paediatric Graves' disease?
    West JD; Cheetham TD; Dane C; Natarajan A
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):797-804. PubMed ID: 25719296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up comparison of short-term versus 1-year antithyroid drug therapy for the thyrotoxicosis of Graves' disease.
    Bouma DJ; Kammer H; Greer MA
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1138-42. PubMed ID: 6182155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of autonomously functioning thyroid nodules at a single institution: radioiodine therapy, surgery, and ethanol injection therapy.
    Yano Y; Sugino K; Akaishi J; Uruno T; Okuwa K; Shibuya H; Kitagawa W; Nagahama M; Ito K; Ito K
    Ann Nucl Med; 2011 Dec; 25(10):749-54. PubMed ID: 21971604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves' disease.
    Cohen RZ; Felner EI; Heiss KF; Wyly JB; Muir AB
    J Pediatr Endocrinol Metab; 2016 Mar; 29(3):319-25. PubMed ID: 26656610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence.
    Barclay ML; Brownlie BE; Turner JG; Wells JE
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):759-64. PubMed ID: 8033366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyrotoxicosis in children: thirty years' experience.
    Raza J; Hindmarsh PC; Brook CG
    Acta Paediatr; 1999 Sep; 88(9):937-41. PubMed ID: 10519332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost effectiveness of treatment modalities for thyrotoxicosis in a U.K. center.
    Patel NN; Abraham P; Buscombe J; Vanderpump MP
    Thyroid; 2006 Jun; 16(6):593-8. PubMed ID: 16839261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.